TARA•benzinga•
Protara Therapeutics Announces 6-Month Data From ADVANCED-2 Trial; Expects New Data Mid-2025, Begins Dosing In THRIVE-3 Trial In H1 2025, Awaits Results For STARBORN-1 Trial By End Of H1 2025.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2025 by benzinga